{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:56:34Z","timestamp":1786323394224,"version":"build-2736575974"},"reference-count":45,"publisher":"Radcliffe Medical Media Ltd","issue":"3","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Card Fail Rev"],"abstract":"<jats:p>Heart failure (HF) is a leading cause of hospitalisation and healthcare costs worldwide. Acute decompensated heart failure accounts for more than 1 million hospitalisations in the US. Despite advances in the quality of acute and chronic HF disease management, gaps in knowledge about effective interventions to support the transition of care for patients with HF remain. Despite multiple trials of promising therapies, standard care consists of decongestion with IV diuretics and haemodynamic support with vasodilators and inotropes and this has remained largely unchanged during the past 45 years. Newer advances in medical innovations and structural heart disease interventions have now given promise to improved survival, outcomes and quality of life for patients with advanced HF of multiple aetiologies. In this article, we focus on structural interventions in the treatment of patients with HF.<\/jats:p>","DOI":"10.15420\/cfr.2019.12.2","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T13:29:31Z","timestamp":1569677371000},"page":"147-154","source":"Crossref","is-referenced-by-count":5,"title":["State-of-the-art Structural Interventions in Heart Failure"],"prefix":"10.15420","volume":"5","author":[{"given":"Jeffrey","family":"Park","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine, Rush University Medical Center, Chicago, IL, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam S","family":"Suradi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine, Rush University Medical Center, Chicago, IL, US"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Mariell J, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18;","DOI":"10.1056\/NEJMra021498"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Epidemiology and risk profile of heart failure","DOI":"10.1038\/nrcardio.2010.165"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"The Euro Heart Survey on adult congenital heart disease","DOI":"10.1093\/eurheartj\/ehi396"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"The prevention of hospital readmissions in heart failure","DOI":"10.1016\/j.pcad.2015.09.004"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Reducing hospital readmission rates: current strategies and future directions","DOI":"10.1146\/annurev-med-022613-090415"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"The epidemiology of valvular heart disease: a growing public health problem","DOI":"10.1016\/j.hfc.2006.09.010"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Pibarot P, Dumesnil JG. New concepts in valvular hemodynamics: implications for diagnosis and treatment of aortic stenosis. Can J Cardiol 2007;23:40B-7.","DOI":"10.1016\/S0828-282X(07)71009-7"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Aortic stenosis: changing disease concepts","DOI":"10.4250\/jcu.2015.23.2.59"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Two-year outcomes after transcatheter or surgical aortic-valve replacement","DOI":"10.1056\/NEJMoa1200384"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"The Troms\u00f8 study","DOI":"10.1136\/heartjnl-2012-302265"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Cardiovascular Health Study","DOI":"10.1016\/S0735-1097(96)00563-3"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Bicuspid aortic valve stenosis: favorable early outcomes with a next-generation transcatheter heart valve in a multicenter study","DOI":"10.1016\/j.jcin.2016.01.002"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Post-TAVR heart failure","DOI":"10.1080\/24748706.2018.1456705"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Muratori M, Fusini L, Tamborini G, et al. Sustained favourable haemodynamics 1 year after TAVI: improvement in NYHA functional class related to improvement of left ventricular diastolic function. Eur Heart J Cardiovas Imaging 17;11:1269-78.","DOI":"10.1093\/ehjci\/jev306"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Nishimura R, Otto CM, Bonow RO, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol 2014;63:e57-e185;","DOI":"10.1016\/j.jacc.2014.02.536"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Very long term follow-up after percutaneous balloon mitral valvuloplasty","DOI":"10.1016\/j.jcin.2018.05.039"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"New scores for the assessment of mitral stenosis using real-time three-dimensional echocardiography","DOI":"10.1007\/s12410-011-9099-z"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Mitral annular calcification and calcific mitral stenosis: therapeutic challenges and considerations","DOI":"10.1007\/s11936-019-0723-6"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Basic mechanisms of mitral regurgitation","DOI":"10.1016\/j.cjca.2014.06.022"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Suradi HS, Kavinsky CJ, Hijazi ZM. Percutaneous mitral valve repair: the MitraClip device. Glob Cardiol Sci Pract 2016;2016:e201617.","DOI":"10.21542\/gcsp.2016.17"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Mitral valve interventions in heart failure","DOI":"10.1002\/ehf2.12287"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Transcatheter mitral-valve repair in patients with heart failure","DOI":"10.1056\/NEJMoa1806640"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique","DOI":"10.1161\/CIRCULATIONAHA.116.024848"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Asmarats L, Puri R, Latib A, et al. Transcatheter tricuspid valve intervention. J Am Coll Cardiol 2018;71:293-556;","DOI":"10.1016\/j.jacc.2018.04.031"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Results of transcatheter pulmonary valvulation in native or patched right ventricular outflow tracts","DOI":"10.1016\/j.acvd.2014.07.045"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Trends in pulmonary valve replacement in children and adults with tetralogy of Fallot","DOI":"10.1016\/j.amjcard.2014.09.054"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Impact of pulmonary valve replacement in tetralogy of Fallot with pulmonary regurgitation: a comparison of intervention and nonintervention","DOI":"10.1016\/j.athoracsur.2012.06.062"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)","DOI":"10.1093\/eurheartj\/ehq249"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Silversides CK, Kiess M, Beauchesne L, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome. Can J Cardiol 2010;26:e80-97.","DOI":"10.1016\/S0828-282X(10)70355-X"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Warnes CA, Williams RG, Bashore TM, et al. ACC\/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008;118:e714-833.","DOI":"10.1161\/CIRCULATIONAHA.108.190690"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"3-year outcomes of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the COMPASSION multicenter clinical trial","DOI":"10.1016\/j.jcin.2018.06.001"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US Melody valve investigational device exemption trial","DOI":"10.1161\/CIRCULATIONAHA.114.013588"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiography study","DOI":"10.1016\/j.jacc.2003.12.060"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Two-year outcomes after transcatheter or surgical aortic-valve replacement","DOI":"10.1056\/NEJMoa1200384"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves)","DOI":"10.1016\/j.jacc.2013.02.087"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2014;148:e1-e132.","DOI":"10.1161\/CIR.0000000000000031"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Transcatheter trans-apical closure of paravalvular mitral and aortic leaks using a new device: first in man experience","DOI":"10.1002\/ccd.25006"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Early experience of percutaneous paravalvular leak closure using a novel Occlutech occluder","DOI":"10.4244\/EIJV11I10A237"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Double balloon technique for dilation of valvular or vessel stenosis in congenital and acquired heart disease","DOI":"10.1016\/S0735-1097(87)80168-7"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Atrial septal defects in the adult: recent progress and overview","DOI":"10.1161\/CIRCULATIONAHA.105.592055"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Natural history of atrial septal defect","DOI":"10.1136\/hrt.32.6.820"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Transcatheter closure of congenital ventricular septal defects: results of the European Registry","DOI":"10.1093\/eurheartj\/ehm314"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43. Nguyen HL, Phan QT, Doan DD, et al. Percutaneous closure of perimembranous ventricular septal defect using patent ductus arteriosus occluders. PLoS One 2018;13:e0206535.","DOI":"10.1371\/journal.pone.0206535"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Patent ductus arteriosus in adults - indications and possibilities for closure","DOI":"10.1007\/s12471-011-0138-9"},{"key":"ref44","unstructured":"45. Kharouf R, Cao QL, Hijazi ZM. Transcatheter closure of coronary artery fistula complicated by myocardial infarction. J Invasive Cardiol 2007;19:E146-9."}],"container-title":["Cardiac Failure Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cfrjournal.com\/articles\/State-Art-Structural-Interventions-in-Heart-Failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:46:19Z","timestamp":1783615579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cfrjournal.com\/articleindex\/cfr.2019.12.2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,11,4]]}},"URL":"https:\/\/doi.org\/10.15420\/cfr.2019.12.2","relation":{},"ISSN":["2057-7559","2057-7540"],"issn-type":[{"value":"2057-7559","type":"electronic"},{"value":"2057-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,4]]}}}